North Korean hackers target drugmakers developing COVID-19 vaccines, treatments

Hackers based in North Korea are launching cyberattacks on drugmakers developing COVID-19 vaccines and treatments in hopes of securing information that can be sold or otherwise weaponized, the Wall Street Journal reported Dec. 2.

Advertisement

The hackers have targeted Johnson & Johnson, Novavax and AstraZeneca, all of which are developing COVID-19 vaccine candidates. South Korean drugmakers with COVID-19 drugs in clinical testing have also been targeted, including Genexine, Shin Poong and Celltrion, sources told the WSJ.

Though it is unclear whether the hackers obtained the information they were seeking, they have been launching cyberattacks on these six drugmakers since August, sources told the WSJ. They also said the cyberattacks contained digital footprints used in previous North Korean hacking campaigns targeting the U.S. Department of State and South Korea’s unification ministry.

More articles on cybersecurity: 
Nearly 1M health records breached in November
Montefiore alerts patients of privacy breach linked to billing scam: 4 details
Beware of insider cyber threats, AMA warns hospitals

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Cybersecurity

Advertisement

Comments are closed.